期刊文献+

以合成肽为抗原检测人巨细胞病毒抗体的酶联免疫吸附试验的建立及评价 被引量:4

Establishment and evaluation of an indirect enzyme-linked immunosorbent assay based on synthetic peptides for the detection of specific antibodies to Human cytomegalovirus
下载PDF
导出
摘要 目的以合成多肽为抗原建立用于人巨细胞病毒(HCMV)抗体检测的间接酶联免疫吸附试验(ELISA)。方法以固相多肽合成技术合成了HCMV 7个抗原性肽段,并对其抗原性进行了初步评价,选择高抗体反应的肽段为抗原,建立检测HCMV特异性抗体的间接ELISA。结果7个肽段中,抗体反应性较高肽段有4个;以合成多肽为抗原的间接ELISA对HCMV IgG抗体检测的敏感性和特异性分别为90.9%和100.0%,对于IgM抗体检测的敏感性和特异性分为90.0%和100.0%;与国外试剂盒测定结果有良好的符合性;该方法的精密度及稳定性良好。结论合成的HCMV多肽片段可作为抗原用于HCMV的检测,以此多肽为抗原建立的间接ELISA可用于临床HCMV特异性抗体的检测。 Objective To establish an indirect enzyme-linked immunosorbent assay (ELISA) for the detection of Human cytomegalovirus (HCMV) specific antibodies, based on synthetic antigenic peptides of HCMV. Methods 7 highly antigenic peptides were synthesized by solid phase peptide synthesis technique, and their antibody reactivity was evaluated by indirect ELISA. Some peptides which had highly antibody reactivity were selected as the antigens and an indirect ELISA was established for the detection of specific antibodies to HCMV. Results There were 4 peptides which had high antibody reactivity among those 7 peptides ; The sensitivities of the indirect ELISA based on the combination of synthetic peptides were 90.9% and 90.0% for the detection of HCMV IgG antibodies and IgM antibodies, and the specificities were both 100.0%. Compared with imported HCMV test kits, there was a good accordance between two assays. The assay had good precision and stability. Conclusions The synthetic peptides could be used as antigens for the detection of HCMV specific antibodies and the indirect ELISA based on these peptides could be used in the detection of HCMV specific antibodies in clinical diagnosis of HCMV infection.
出处 《检验医学》 CAS 北大核心 2008年第6期604-607,共4页 Laboratory Medicine
关键词 人巨细胞病毒 合成肽 酶联免疫吸附试验 Human cytomegalovirus Synthetic peptide Enzyme-linked immunosorbent assay
  • 相关文献

参考文献9

  • 1Distefano AL, Alonso A, Martin F,et al. Human cytomegalovirus: detection of congenital and perinatal infection in Argentina [ J ]. BMC Pediatr, 2004,23 ( 1 ) : 11.
  • 2Revello MG, Gerna G. Diagnosis and management of Human cytomegalovirus infection in the mother, fetus, and newborn infant. [ J]. Clin Microbiol Rev,2002,15 (4) :680-715.
  • 3Revello MG, Percivalle E, Gerna G. Immunoglobulin M to the membrane of uninfected fibroblasts in primary Human cytomegalovirus infections [ J ]. Mierobiologica, 1986,9(2) :127-138.
  • 4Severi B, Landini MP, Govoni E. Human cytomegalovirus morphogenesis : an ultrastructural study of the late cytoplasmic phases [ J ]. Arch Virol, 1988,98 ( 1-2 ) : 51-64.
  • 5Greijer AE, Van De Crommert JM, Stevens SJ, et al. Molecular fine-specificity analysis of antibody respon- ses to Human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays [ J ]. J Clin Microbiol, 1999,37 ( 1 ) : 179-188.
  • 6Takahashi I, Sugiura S, Ohta H, et al. Epitope analysis of antibodies in Japanese to Human cytomegalovirus phosphoprotein 150 with synthetic peptides [ J ] Biosci Biotechnol Biochem, 2002,66 ( 11 ) : 2402-2405.
  • 7卢银平,董继华,曹伟,熊腊香.合成肽检测巨细胞病毒酶联免疫方法的建立及应用[J].中国医师杂志,2002,4(8):852-854. 被引量:4
  • 8Genser B, Truschnig-Wilders M, Stunzner D, et al. Evaluation of five commercial enzyme immunoassays for the detection of Human cytomegalovirus-specific IgM antibodies in the absence of a commercially avail- able gold standard[ J]. Clin Chem Lab Med,2001,39 ( 1 ) :62-70.
  • 9Sun A, Chang JG, Kao CLet al. Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behcet's disease[Jl. J Oral Pathol Med, 1996,25 (5) :212-218.

二级参考文献9

  • 1Britt WJ,Vugler CG.Antiviral antibody responses in mother and newborn infants with clinical and subclinical congenital cytomegalovirus infections[J] .J infect Dis,1990,161:214~218
  • 2Cope AV,Swenyp P,Sabin C,et al.Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation[J] .J Med Virol,1997,52:200~205
  • 3Limaye AP,Bowden RA,Myerson D,et al.Cytomegalovirus disease occurring before engraftment in marrow transplant recipient[J].Clin Infect Dis,1997,2 4:830~835
  • 4Gerna G,Revello MG,Percivalle E,et al.Quantity of human cytomegaloviru s by using monoclonal antibodies to different viral proteins[J].J Clin Microb ilol,1990,28:2681~2688
  • 5Emery VC,Cope AV,Bowen EF.The dynamics of human cytomegalovirus replic ation in vivo[J].J Exp Med,1999,190:177~182
  • 6Sara BM,Joan KK,Alexander JR,et al.Cervical shedding of cytomegaloviru s in human immunodeficiency virus Typel-infected women[J].J Med virol,1999, 59:469~473
  • 7Stagno S.In:Remington JS,Klein JO editor.Infectous diseases of the fet us and newborn infant[J].Philadelphia:WB saunder CO.,1995,312~353
  • 8Ljungdahl-stahle E,Schloss L,Sundqvist VA,et al.Solid phase ELISA for determination of the virus dose dependent sensitivity of human cytomegalovirus t o antiviral drugs in vitro[J].Antiviral Res,1998,40:105~112
  • 9Numazaki K,Chiba S.Current aspects of diagnosis and treatment of cytom egalovirus infections in infants[J].Clin Diagn Virol,1997,8:169~181

共引文献3

同被引文献38

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部